Methamphetamine use disorder. Other psychoactive substance abuse
Conditions
Interventions
Intervention 1: Intervention group:In the first week, they will receive one pill containing Mirtazapine 15 mg and then two pills of 15 mg, which will continue until the 12th week, and in the 12th week
Sponsors
University of social welfare and rehabilitation sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Having informed consent Methamphetamine use disorder based on DSM-5 criteria Normal pre-intervention laboratory results including blood cell count, liver and kidney function indicators, fasting blood sugar and normal lipid profile. Age 18 to 65 years
Exclusion criteria
Exclusion criteria: Acute or chronic physical disorder (acute infection, history of cardiovascular, liver or kidney diseases) during the last three months primary psychiatric disorder (substance induced psychotic and mood disorders are excluded) History of taking antidepressants during the last four weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The craving to use methamphetamine. Timepoint: At the beginning of the study and then in weeks 4, 8 and 12. Method of measurement: Questionnaire measuring the craving to use substance after quitting.;Use methamphetamine. Timepoint: At the beginning of the study and then in weeks 4, 8 and 12. Method of measurement: Patient self-report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRonak Mihan
University of social welfare and rehabilitation sciences
Outcome results
None listed